Albert Bourla, Chairman & CEO at PFIZER INC (PFE), bought 38,000 shares at $26.34 ($1.0M) on 2026-08-12, disclosed to the SEC on 2026-08-12.
Pfizer Chairman and CEO Albert Bourla purchased $1.0 million of stock at $26.34, marking the largest insider purchase of his career and a reversal of his recent selling pattern. This high-profile buy suggests management confidence in the company's valuation and future prospects.
PFE is trading at $26.31, up 7.48% over the last 30 days but still 8.44% below its 52-week high of $28.74. The stock has recently rebounded from a five-year low of roughly 28% decline, currently sitting 11.58% above its 52-week low.
1) Q2 earnings on August 14, 2026, which triggered a 'post-earnings insider buying spree' according to Barrons.com. 2) The company is paying a $44 million settlement for Chantix lawsuits, with claims due by September 14, 2026. 3) The current insider buying cluster of 2 other insiders in the last 30 days suggests a broader management commitment.
1) The stock is currently trading at a P/E of 35.25, which Simply Wall St. notes is 'stretched on earnings' relative to the company's five-year performance. 2) The company recently settled a $44 million lawsuit regarding Chantix, which could impact future financials.
Something here stands out, but not much.
| Filing → |